Market Closed -
Nyse
01:30:02 27/04/2024 am IST
|
5-day change
|
1st Jan Change
|
102.1
USD
|
+2.46%
|
|
+1.38%
|
+7.41%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
31,501
|
30,607
|
30,477
|
27,037
|
30,840
|
33,256
|
-
|
-
|
Enterprise Value (EV)
1 |
42,509
|
44,099
|
40,248
|
36,207
|
38,667
|
41,884
|
41,139
|
41,016
|
P/E ratio
|
9.86
x
|
21.6
x
|
5.51
x
|
7.03
x
|
41.5
x
|
12.6
x
|
10.2
x
|
10.2
x
|
Yield
|
4.39%
|
4.58%
|
4.81%
|
5.66%
|
5.2%
|
5%
|
5.21%
|
5.48%
|
Capitalization / Revenue
|
0.91
x
|
1.1
x
|
0.66
x
|
0.54
x
|
0.75
x
|
0.86
x
|
0.94
x
|
0.95
x
|
EV / Revenue
|
1.22
x
|
1.59
x
|
0.87
x
|
0.72
x
|
0.94
x
|
1.09
x
|
1.17
x
|
1.17
x
|
EV / EBITDA
|
7.47
x
|
13.4
x
|
4.63
x
|
5.55
x
|
7.4
x
|
8.29
x
|
7.2
x
|
6.93
x
|
EV / FCF
|
18.8
x
|
30.3
x
|
7.02
x
|
8.56
x
|
11.3
x
|
21.5
x
|
13.6
x
|
17.4
x
|
FCF Yield
|
5.33%
|
3.3%
|
14.3%
|
11.7%
|
8.82%
|
4.64%
|
7.34%
|
5.74%
|
Price to Book
|
3.92
x
|
3.85
x
|
2.61
x
|
2.14
x
|
2.38
x
|
2.49
x
|
2.42
x
|
2.33
x
|
Nbr of stocks (in thousands)
|
3,33,411
|
3,33,919
|
3,30,441
|
3,25,624
|
3,24,362
|
3,25,622
|
-
|
-
|
Reference price
2 |
94.48
|
91.66
|
92.23
|
83.03
|
95.08
|
102.1
|
102.1
|
102.1
|
Announcement Date
|
31/01/20
|
29/01/21
|
28/01/22
|
03/02/23
|
02/02/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
34,727
|
27,753
|
46,173
|
50,451
|
41,107
|
38,540
|
35,203
|
34,917
|
EBITDA
1 |
5,692
|
3,285
|
8,689
|
6,527
|
5,222
|
5,052
|
5,716
|
5,918
|
EBIT
1 |
4,380
|
1,900
|
7,397
|
5,170
|
3,766
|
3,582
|
4,247
|
4,429
|
Operating Margin
|
12.61%
|
6.85%
|
16.02%
|
10.25%
|
9.16%
|
9.29%
|
12.07%
|
12.68%
|
Earnings before Tax (EBT)
1 |
4,052
|
1,386
|
6,786
|
4,776
|
2,627
|
3,347
|
4,062
|
4,406
|
Net income
1 |
3,390
|
1,420
|
5,617
|
3,889
|
2,114
|
2,652
|
3,207
|
3,493
|
Net margin
|
9.76%
|
5.12%
|
12.17%
|
7.71%
|
5.14%
|
6.88%
|
9.11%
|
10%
|
EPS
2 |
9.580
|
4.240
|
16.75
|
11.81
|
2.290
|
8.116
|
10.05
|
10.02
|
Free Cash Flow
1 |
2,267
|
1,457
|
5,736
|
4,229
|
3,411
|
1,944
|
3,019
|
2,353
|
FCF margin
|
6.53%
|
5.25%
|
12.42%
|
8.38%
|
8.3%
|
5.04%
|
8.58%
|
6.74%
|
FCF Conversion (EBITDA)
|
39.83%
|
44.35%
|
66.01%
|
64.79%
|
65.32%
|
38.48%
|
52.81%
|
39.76%
|
FCF Conversion (Net income)
|
66.87%
|
102.61%
|
102.12%
|
108.74%
|
161.35%
|
73.29%
|
94.13%
|
67.36%
|
Dividend per Share
2 |
4.150
|
4.200
|
4.440
|
4.700
|
4.940
|
5.110
|
5.317
|
5.596
|
Announcement Date
|
31/01/20
|
29/01/21
|
28/01/22
|
03/02/23
|
02/02/24
|
-
|
-
|
-
|
Fiscal Period: December |
2021 Q3
|
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
---|
Net sales
1 |
12,700
|
12,830
|
13,157
|
14,838
|
12,250
|
10,206
|
10,247
|
10,306
|
10,625
|
9,929
|
9,925
|
10,233
|
10,696
|
10,039
|
9,388
|
EBITDA
1 |
2,691
|
1,395
|
2,020
|
2,381
|
1,192
|
865
|
1,452
|
1,450
|
1,410
|
910
|
1,063
|
1,382
|
1,494
|
1,285
|
1,306
|
EBIT
1 |
2,248
|
1,535
|
1,661
|
2,210
|
896
|
487
|
713
|
1,122
|
1,068
|
586
|
698
|
977.6
|
1,094
|
854.1
|
932.3
|
Operating Margin
|
17.7%
|
11.96%
|
12.62%
|
14.89%
|
7.31%
|
4.77%
|
6.96%
|
10.89%
|
10.05%
|
5.9%
|
7.03%
|
9.55%
|
10.23%
|
8.51%
|
9.93%
|
Earnings before Tax (EBT)
1 |
2,215
|
866
|
1,635
|
2,023
|
727
|
389
|
642
|
905
|
901
|
179
|
596
|
902.4
|
1,017
|
791.6
|
940
|
Net income
1 |
1,762
|
726
|
1,320
|
1,644
|
572
|
353
|
474
|
715
|
747
|
183
|
473
|
720.8
|
809.9
|
640.7
|
743
|
Net margin
|
13.87%
|
5.66%
|
10.03%
|
11.08%
|
4.67%
|
3.46%
|
4.63%
|
6.94%
|
7.03%
|
1.84%
|
4.77%
|
7.04%
|
7.57%
|
6.38%
|
7.91%
|
EPS
2 |
5.250
|
2.180
|
4.000
|
4.980
|
1.750
|
1.070
|
1.440
|
2.180
|
2.290
|
0.5600
|
1.440
|
2.210
|
2.478
|
2.027
|
2.290
|
Dividend per Share
2 |
1.130
|
1.130
|
1.130
|
1.190
|
1.190
|
1.190
|
1.190
|
1.250
|
1.250
|
1.250
|
1.276
|
1.299
|
1.299
|
1.317
|
1.356
|
Announcement Date
|
29/10/21
|
28/01/22
|
29/04/22
|
29/07/22
|
28/10/22
|
03/02/23
|
28/04/23
|
04/08/23
|
27/10/23
|
02/02/24
|
26/04/24
|
-
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
11,008
|
13,492
|
9,771
|
9,170
|
7,827
|
8,628
|
7,883
|
7,761
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
1.934
x
|
4.107
x
|
1.125
x
|
1.405
x
|
1.499
x
|
1.708
x
|
1.379
x
|
1.311
x
|
Free Cash Flow
1 |
2,267
|
1,457
|
5,736
|
4,229
|
3,411
|
1,944
|
3,019
|
2,353
|
ROE (net income / shareholders' equity)
|
37.2%
|
23.5%
|
56.7%
|
33.5%
|
22.2%
|
20%
|
21.6%
|
22.5%
|
ROA (Net income/ Total Assets)
|
11.6%
|
5.72%
|
15.6%
|
11.2%
|
7.74%
|
6.87%
|
7.81%
|
8.66%
|
Assets
1 |
29,261
|
24,812
|
36,034
|
34,655
|
27,324
|
38,625
|
41,073
|
40,311
|
Book Value Per Share
2 |
24.10
|
23.80
|
35.40
|
38.70
|
39.90
|
41.00
|
42.10
|
43.80
|
Cash Flow per Share
2 |
14.00
|
10.20
|
22.70
|
18.70
|
15.20
|
13.40
|
16.00
|
15.50
|
Capex
1 |
2,700
|
1,947
|
1,866
|
1,890
|
1,531
|
2,100
|
2,147
|
2,271
|
Capex / Sales
|
7.77%
|
7.02%
|
4.04%
|
3.75%
|
3.72%
|
5.45%
|
6.1%
|
6.5%
|
Announcement Date
|
31/01/20
|
29/01/21
|
28/01/22
|
03/02/23
|
02/02/24
|
-
|
-
|
-
|
Last Close Price
102.1
USD Average target price
104.4
USD Spread / Average Target +2.25% Consensus |
1st Jan change
|
Capi.
|
---|
| +7.41% | 33.24B | | +5.14% | 103B | | -5.63% | 63.04B | | +39.52% | 39.06B | | +12.91% | 37.58B | | +6.85% | 19.22B | | +12.86% | 16.83B | | +7.73% | 15.03B | | +16.93% | 14.96B | | -16.39% | 13.52B |
Other Commodity Chemicals
|